| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
National Cancer Institute, Laboratory of Tumor Immunology and Biology, Tumor Growth Factor Section [A. D. E., C. W., B. W-J., I. M-L., C. B., D. S. S.] and National Institute of Neurological Disorders and Stroke, Surgical Neurology Branch [S. F.], National Institutes of Health, Bethesda, Maryland 20892; Free University Berlin, Medical Center Benjamin Franklin, Department of Obstetrics and Gynecology, 12200 Berlin, Germany [A. D. E., H. K. W.]; Faculty of Engineering, Department of Bioscience and Biotechnology, Okayama University, Okayama 700-8530, Japan [M. S.]; and Walter Reed Army Institute of Research, Department of Molecular Pathology, Washington, D.C. 20307 [M. D. S.]
Cripto-1 (CR-1), a member of the epidermal growth factor-CFC peptide family, activates the ras/raf/mitogen-activated protein/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway. In the present study, the role of CR-1 in the phosphatidylinositol 3'-kinase (PI3K)/AKT (protein kinase B)/glycogen synthase kinase 3ß (GSK-3ß)-dependent signaling pathway was evaluated in human SiHa cervical carcinoma cells. Our data demonstrate that CR-1 can enhance the tyrosine phosphorylation of the p85 regulatory subunit of PI3K and transiently induce the phosphorylation of AKT in a time- and dose-dependent manner. In addition, CR-1 was found to induce the phosphorylation of GSK-3ß. Phosphorylation of AKT and GSK-3ß by CR-1 can be blocked by LY294002, a specific inhibitor of PI3K, thus leading to apoptosis. Finally, the apoptotic effect of LY294002 can be partially rescued by exogenous CR-1. In summary, our data suggest that human CR-1 may function as a survival factor through a PI3K-dependent signaling pathway involving AKT and GSK-3ß.
This article has been cited by other articles:
![]() |
C. Bianco, L. Strizzi, M. Mancino, K. Watanabe, M. Gonzales, S. Hamada, A. Raafat, L. Sahlah, C. Chang, F. Sotgia, et al. Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial Cells Am. J. Pathol., February 1, 2008; 172(2): 345 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shi, C. Ge, Y. Luo, X. Hou, R. S. Haltiwanger, and P. Stanley The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling J. Biol. Chem., July 13, 2007; 282(28): 20133 - 20141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Gray, G. Shani, K. Aung, J. Kelber, and W. Vale Cripto Binds Transforming Growth Factor {beta} (TGF-{beta}) and Inhibits TGF-{beta} Signaling Mol. Cell. Biol., December 15, 2006; 26(24): 9268 - 9278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chu, J. Ding, K. Jeays-Ward, S. M. Price, M. Placzek, and M. M. Shen Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis Development, December 15, 2005; 132(24): 5539 - 5551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Strizzi, C. Bianco, A. Raafat, W. Abdallah, C. Chang, D. Raafat, M. Hirota, S. Hamada, Y. Sun, N. Normanno, et al. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo J. Cell Sci., October 15, 2005; 118(20): 4633 - 4643. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bianco, L. Strizzi, A. Ebert, C. Chang, A. Rehman, N. Normanno, L. Guedez, R. Salloum, E. Ginsburg, Y. Sun, et al. Role of Human Cripto-1 in Tumor Angiogenesis J Natl Cancer Inst, January 19, 2005; 97(2): 132 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. X. Xing, X. F. Hu, G. A. Pietersz, H. L. Hosick, and I. F. C. McKenzie Cripto: A Novel Target for Antibody-Based Cancer Immunotherapy Cancer Res., June 1, 2004; 64(11): 4018 - 4023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bianco, H. B. Adkins, C. Wechselberger, M. Seno, N. Normanno, A. De Luca, Y. Sun, N. Khan, N. Kenney, A. Ebert, et al. Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells Mol. Cell. Biol., April 15, 2002; 22(8): 2586 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Panka, T. Mano, T. Suhara, K. Walsh, and J. W. Mier Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells J. Biol. Chem., March 2, 2001; 276(10): 6893 - 6896. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |